SciELO - Scientific Electronic Library Online

 
vol.76 suppl.2Cardiovascular risk stratificationBiventricular resynchronization in the treatment of chronic heart failure author indexsubject indexsearch form
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Archivos de cardiología de México

On-line version ISSN 1665-1731Print version ISSN 1405-9940

Abstract

MENDEZ ORTIZ, Arturo. Pathophysiology of heart failure. Arch. Cardiol. Méx. [online]. 2006, vol.76, suppl.2, pp.182-187. ISSN 1665-1731.

Treatment of heart failure has been successfully target biologically, to counteract deleterious effects resulting from neuroendocrine activation, with the use of several agents (e.g., angiotensine-converting enzyme inhibitors, beta-adrenergic receptor blockers, spironolactone), that provide benefical effects, demonstrated in multicentric trials in controlled populations. However, this mid-term benefit, becomes less effective with time, resulting in progression of the disease to terminal stages and death. The purpose of this paper is to review other pathophysiologic pathways and the potential application of preventive measures to be incorporated in the standardized treatment of heart failure.

Keywords : Neuroendocrine activation; Apoptosis; Inflammation; Oxidative stress.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License